Improvement in Motor and Walking Capacity during Multisegmental Transcutaneous Spinal Stimulation in Individuals with Incomplete Spinal Cord Injury
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms25084480 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Hatice Kumru und 6 weiteren Autor:innen. Beteiligte Einrichtung: Fundación Institut Guttmann, Institut Universitari de NeurorehabilitacióAdscrit a la UAB, 08916 Badalona, Spain. Hauptthemen laut MEDLINE: Spinal Cord Injuries, Walking, Spinal Cord Stimulation. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: ERDF A way of making Europe, National Institutes of Health-NINDS, State funding allocated to the Pavlov Institute of Physiology Russian Academy of Sciences.
Abstract (Originalsprache)
Transcutaneous multisegmental spinal cord stimulation (tSCS) has shown superior efficacy in modulating spinal locomotor circuits compared to single-site stimulation in individuals with spinal cord injury (SCI). Building on these findings, we hypothesized that administering a single session of tSCS at multiple spinal segments may yield greater enhancements in muscle strength and gait function during stimulation compared to tSCS at only one or two segments. In our study, tSCS was applied at single segments (C5, L1, and Coc1), two segments (C5-L1, C5-Coc1, and L1-Coc1), or multisegments (C5-L1-Coc1) in a randomized order. We evaluated the 6-m walking test (6MWT) and maximum voluntary contraction (MVC) and assessed the Hmax/Mmax ratio during stimulation in ten individuals with incomplete motor SCI. Our findings indicate that multisegmental tSCS improved walking time and reduced spinal cord excitability, as measured by the Hmax/Mmax ratio, similar to some single or two-site tSCS interventions. However, only multisegmental tSCS resulted in increased tibialis anterior (TA) muscle strength. These results suggest that multisegmental tSCS holds promise for enhancing walking capacity, increasing muscle strength, and altering spinal cord excitability in individuals with incomplete SCI.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Fundación Institut Guttmann, Institut Universitari de NeurorehabilitacióAdscrit a la UAB, 08916 Badalona, Spain.
- Universitat Autònoma de Barcelona, 08193 Barcelona, Spain.
- Fundació Institut d'Investigació en Ciències de la Salut Germans Trias i Pujol, 08916 Badalona, Spain.
- Pavlov Institute of Physiology, St. Petersburg 199034, Russia.
- Department of Physiology and Biophysics, University of Louisville, Louisville, KY 40292, USA.
ORCID-Profile: Hatice Kumru, Joan Vidal, Yury Gerasimenko
Förderung
- ERDF A way of making Europe
- National Institutes of Health-NINDS
- State funding allocated to the Pavlov Institute of Physiology Russian Academy of Sciences
Zitieren
APA
Kumru, H., Ros-Alsina, A., García Alén, L., Vidal, J., Gerasimenko, Y., Hernandez, A., & Wrigth, M. (2024). Improvement in Motor and Walking Capacity during Multisegmental Transcutaneous Spinal Stimulation in Individuals with Incomplete Spinal Cord Injury. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25084480
Vancouver
Kumru H, Ros-Alsina A, García Alén L, Vidal J, Gerasimenko Y, Hernandez A, et al. Improvement in Motor and Walking Capacity during Multisegmental Transcutaneous Spinal Stimulation in Individuals with Incomplete Spinal Cord Injury. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25084480
BibTeX
@article{Kumru2024,
author = {Kumru, Hatice and Ros-Alsina, Aina and García Alén, Loreto and Vidal, Joan and Gerasimenko, Yury and Hernandez, Agusti and Wrigth, Mark},
title = {Improvement in Motor and Walking Capacity during Multisegmental Transcutaneous Spinal Stimulation in Individuals with Incomplete Spinal Cord Injury},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms25084480}
}
EUVIMED